日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A potent inhibitor of PAI-1, MDI-2517, mitigates disease severity in a preclinical systemic sclerosis model

PAI-1 的强效抑制剂 MDI-2517 可减轻临床前系统性硬化症模型中的疾病严重程度。

Su, Enming J; Tsou, Pei-Suen; Warnock, Mark; Subbotina, Natalya; Mann, Kris; Vichaikul, Sirapa; Rosek, Alyssa; Leung, Lisa; Xing, Xianying; Xing, Enze; Plazyo, Olesya; Bogle, Rachael; Tsoi, Lam C; Emal, Cory D; Khanna, Dinesh; Varga, John; Sisson, Thomas H; Gudjonsson, Johann E; Lawrence, Daniel A

Targeting Plasminogen Activator Inhibitor-1 with a Novel Small Molecule Inhibitor Attenuates Lung Fibrosis.

利用新型小分子抑制剂靶向纤溶酶原激活物抑制剂-1可减轻肺纤维化

Sisson Thomas H, Fortier Sean, Tsoi Lam C, Alonzo Roxann, Subbotina Natalya, Warnock Mark, Mann Kris, Gutor Sergey S, Hartman J Craig, Gudjonsson Johann E, Su Enming J, Emal Cory D, Lawrence Daniel A

Imatinib treatment reduces brain injury in a murine model of traumatic brain injury

伊马替尼治疗可减轻小鼠创伤性脑损伤模型中的脑损伤。

Su, Enming J; Fredriksson, Linda; Kanzawa, Mia; Moore, Shannon; Folestad, Erika; Stevenson, Tamara K; Nilsson, Ingrid; Sashindranath, Maithili; Schielke, Gerald P; Warnock, Mark; Ragsdale, Margaret; Mann, Kris; Lawrence, Anna-Lisa E; Medcalf, Robert L; Eriksson, Ulf; Murphy, Geoffrey G; Lawrence, Daniel A